Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study
- DOI
- 10.1016/j.jhep.2025.05.003
- Published
- 2025-11
- Container
- Journal of Hepatology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jhep.2025.05.003,
title = {Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study},
author = {Do-Youn Oh and Aiwu Ruth He and Shukui Qin and Li-Tzong Chen and Takuji Okusaka and Jin Won Kim and Thatthan Suksombooncharoen and Myung Ah Lee and Masayuki Kitano and Howard A. Burris and Mohamed Bouattour and Suebpong Tanasanvimon and Renata Zaucha and Antonio Avallone and Juan Cundom and Aleksandra Kuzko and Julie Wang and Ioannis Xynos and Arndt Vogel and Juan W. Valle},
year = {2025},
journal = {Journal of Hepatology},
doi = {10.1016/j.jhep.2025.05.003},
url = {https://doi.org/10.1016/j.jhep.2025.05.003}
}RIS
TY - JOUR TI - Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study AU - Do-Youn Oh AU - Aiwu Ruth He AU - Shukui Qin AU - Li-Tzong Chen AU - Takuji Okusaka AU - Jin Won Kim AU - Thatthan Suksombooncharoen AU - Myung Ah Lee AU - Masayuki Kitano AU - Howard A. Burris AU - Mohamed Bouattour AU - Suebpong Tanasanvimon AU - Renata Zaucha AU - Antonio Avallone AU - Juan Cundom AU - Aleksandra Kuzko AU - Julie Wang AU - Ioannis Xynos AU - Arndt Vogel AU - Juan W. Valle PY - 2025 JO - Journal of Hepatology DO - 10.1016/j.jhep.2025.05.003 UR - https://doi.org/10.1016/j.jhep.2025.05.003 ER -
APA
Oh, D., He, A. R., Qin, S., Chen, L., Okusaka, T., Kim, J. W., Suksombooncharoen, T., Lee, M. A., Kitano, M., Burris, H. A., Bouattour, M., Tanasanvimon, S., Zaucha, R., Avallone, A., Cundom, J., Kuzko, A., Wang, J., Xynos, I., Vogel, A., & Valle, J. W. (2025). Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2025.05.003
Source records
- crossref · retrieved 2026-09-27T01:31:07.215Z